Synthesis of conformationally constrained analogues of linezolid: Structure-activity relationship (SAR) studies on selected novel tricyclic oxazolidinones

被引:64
作者
Selvakumar, N [1 ]
Srinivas, D [1 ]
Khera, MK [1 ]
Kumar, MS [1 ]
Mamidi, RNVS [1 ]
Sarnaik, H [1 ]
Charavaryamath, C [1 ]
Rao, BS [1 ]
Raheem, MA [1 ]
Das, J [1 ]
Iqbal, J [1 ]
Rajagopalan, R [1 ]
机构
[1] Dr Reddys Res Fdn, Anti Infect Discovery Grp, Hyderabad 500050, Andhra Pradesh, India
关键词
D O I
10.1021/jm020092y
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In an effort to discover potent antibacterials based on the entropically favored "bioactive conformation" approach, we have designed and synthesized a series of novel tricyclic molecules mimicking the conformationally constrained structure of the oxazolidinone antibacterial, Linezolid 1. The structure 3 obtained by this approach was synthesized and found to be moderately active against a panel of Gram-positive organisms tested. Further introduction of a fluorine atom in the aromatic ring of compound 3 as in Linezolid resulted in some excellent compounds possessing potent antibacterial activity. The thus obtained lead molecule 16 was further fine-tuned by structure-activity relationship studies on the amide functionality leading to a number of novel tricyclic oxazolidinone derivatives. Some particularly interesting compounds include the thioamides 36 and 37, thiocarbamate 41, and thiourea 45. The in vitro activity results of amide homologues of 16 (compounds 25-30) revealed that compounds up to four carbon atoms on the amide, nitrogen retain the activity. In general, thioamides and thiocarbamates are more potent when compared to the corresponding amides and carbamates.
引用
收藏
页码:3953 / 3962
页数:10
相关论文
共 25 条
[1]   Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity [J].
Barbachyn, MR ;
Hutchinson, DK ;
Brickner, SJ ;
Cynamon, MH ;
Kilburn, JO ;
Klemens, SP ;
Glickman, SE ;
Grega, KC ;
Hendges, SK ;
Toops, DS ;
Ford, CW ;
Zurenko, GE .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (03) :680-685
[2]  
Brickner SJ, 1996, CURR PHARM DESIGN, V2, P175
[3]   Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant Gram-positive bacterial infections [J].
Brickner, SJ ;
Hutchinson, DK ;
Barbachyn, MR ;
Manninen, PR ;
Ulanowicz, DA ;
Garmon, SA ;
Grega, KC ;
Hendges, SK ;
Toops, DS ;
Ford, CW ;
Zurenko, GE .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (03) :673-679
[4]  
BRUMFITT W, 1994, DRUG EXP CLIN RES, V20, P215
[5]   THIONATION REACTIONS OF LAWESSON REAGENTS [J].
CAVA, MP ;
LEVINSON, MI .
TETRAHEDRON, 1985, 41 (22) :5061-5087
[6]  
Dresser LD, 1998, PHARMACOTHERAPY, V18, P456
[7]   ANTIBACTERIALS - SYNTHESIS AND STRUCTURE ACTIVITY STUDIES OF 3-ARYL-2-OXOOXAZOLIDINES .1. THE B-GROUP [J].
GREGORY, WA ;
BRITTELLI, DR ;
WANG, CLJ ;
WUONOLA, MA ;
MCRIPLEY, RJ ;
EUSTICE, DC ;
EBERLY, VS ;
BARTHOLOMEW, PT ;
SLEE, AM ;
FORBES, M .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (08) :1673-1681
[8]   ANTIBACTERIALS - SYNTHESIS AND STRUCTURE ACTIVITY STUDIES OF 3-ARYL-2-OXOOXAZOLIDINES .2. THE A GROUP [J].
GREGORY, WA ;
BRITTELLI, DR ;
WANG, CLJ ;
KEZAR, HS ;
CARLSON, RK ;
PARK, CH ;
CORLESS, PF ;
MILLER, SJ ;
RAJAGOPALAN, P ;
WUONOLA, MA ;
MCRIPLEY, RJ ;
EBERLY, VS ;
SLEE, AM ;
FORBES, M .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (09) :2569-2578
[9]   Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility [J].
Hiramatsu, K ;
Hanaki, H ;
Ino, T ;
Yabuta, K ;
Oguri, T ;
Tenover, FC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (01) :135-136
[10]   The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin [J].
Lin, AH ;
Murray, RW ;
Vidmar, TJ ;
Marotti, KR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (10) :2127-2131